Among patients with type 2 diabetes, no differences were found with biguanides vs DPP-4 inhibitors in major cardiac or cerebrovascular events, diabetic complications, or death. Biguanides vs ...

In patients with type 2 diabetes, GLP-1 receptor agonists and SGLT2 inhibitors have similar kidney and cardiovascular outcomes. Similar kidney and cardiovascular outcomes are found with glucagon-like ...

Findings confirm a substantial risk of cardiovascular and all-cause mortality as well as graft failure in kidney transplant recipients who develop post-transplant diabetes. Post-kidney transplant ...

Hot flashes (HFs) may pose a larger burden during the second half of the night, according to a study presented.

Lignan consumption, including total lignans, matairesinol, pinoresinol, and secoisolariciresinol, was associated with lower type 2 diabetes risk.

Diabetic microvascular complications were reduced among patients with resolved PTSD symptoms compared with those with persistent PTSD.

A study has found that a moderate amount of moderate-to-vigorous physical activity helps reduce stroke risk regardless of hypertension status.

Low adoption of evidence-based treatment practices for addiction and substance use is primarily attributed to institutional barriers.

The proportion of US patients reporting a lot of trust for physicians and hospitals decreased by about 30% over the COVID-19 pandemic.

For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent.

The BUN to serum albumin ratio could be a simple and useful prognostic tool to gauge survival odds in ICU patients with diabetes and CKD. In patients with type 2 diabetes mellitus and chronic kidney ...

Short-term ICS use in asthma, at moderate to high doses daily, may lead to significant but uncommon risk for adverse CV and pulmonary outcomes.